Fed Governor Cook sues Trump over firing attempt
Haleon plc (LSE/NYSE:HLN), a global consumer health company, disclosed today that Adrian Morris, its General Counsel and Person Discharging Managerial Responsibilities (PDMR), acquired shares under the company’s Share Reward Plan. On Monday, Morris purchased 31 ordinary shares at £4.03 each and was awarded an additional 31 matching shares at no cost, totaling 62 shares. Tamara Rogers, Chief Marketing Officer and PDMR, participated in the same transaction structure and on the same date.
These transactions are part of Haleon’s incentive plan, which aims to align the interests of the company’s executives with those of its shareholders. The purchases and corresponding awards were conducted on the London Stock Exchange (LON:LSEG).
The notification of these transactions comes in accordance with the UK Market Abuse Regulation, which mandates public disclosure of transactions by PDMRs.
Haleon, known for brands like Advil, Centrum, and Sensodyne, specializes in products across Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health, and Therapeutic Skin Health.
The information provided is based on a press release statement and is intended for informational purposes only, reflecting the company’s adherence to regulatory requirements and its commitment to transparency in executive dealings.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.